Latest filing published 13 Jul 2026 for MoonLake Immunotherapeutics, €594k. Read the official filing
da Silva Jorge Santos appears in our data through filings on MoonLake Immunotherapeutics shares, published by SEC (Form 4). Over a trading history stretching from 1 October 2023 to 10 July 2026, the count stands at 11 filings.
Sales make up the whole of the open-market record (8 sales, €10.2M). Other entries cover 1 share grant. Since January 2026: no purchases and 4 sales on the market.
Most recently, on 13 July 2026, the filings show an open-market sale worth €594k in MoonLake Immunotherapeutics. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations